Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

How much do you think the B-OM Phase 3 will cost? Will they need the current facility to conduct it?

Here's the thing. You asked me....
"How many indications are still untested in the B franchise alone?" and noted that "there are still potential drugs untested in the company’s IP."

My only concern about the renewal was the fixed cash burden. Many moons ago...the last time cash created a requirement for a strategy decision...a drug candidate deemed to be a lock was dropped (shelved, abandoned, whatever). No partner was found (sought?). I don't want this post to be the excuse for bringing that up again, but your current argument has a familiar ring to it.

It seems a bit incongruous to be suggesting that the Company should be funding space to pursue untested drugs when it has a "lock" in the closet and a P3 presumably ready to go. It may be worth noting that both of those candidates were purchased and that the "inventor" of the Company's other candidates isn't taking up lab space anymore.